Direct-to-consumer genomics on the scales of autonomy
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Direct-to-consumer (DTC) genetic services have generated enormous controversy from their first emergence. A dramatic recent manifestation of this is the Food and Drug Administration's (FDA) cease and desist order against 23andMe, the leading provider in the market. Critics have argued for the restrictive regulation of such services, and even their prohibition, on the grounds of the harm they pose to consumers. Their advocates, by contrast, defend them as a means of enhancing the autonomy of those same consumers. Autonomy emerges as a key battle-field in this debate, because many of the ‘harm’ arguments can be interpreted as identifying threats to autonomy. This paper assesses whether DTC genomic services are a threat to, or instead, an enhancement of, personal autonomy. It deploys Joseph Raz's account of personal autonomy, with its emphasis on choice from a range of valuable options. It then seeks to counter claims that DTC genomics threatens autonomy because it involves manipulation in contravention of consumers’ independence or because it does not generate valuable options which can be meaningfully engaged with by consumers. It is stressed that the value of the options generated by DTC genomics should not be judged exclusively from the perspective of medical actionability, but should take into consideration plural utilities. Finally, the paper ends by broaching policy recommendations, suggesting that there is a strong autonomy-based argument for permitting DTC genomic services, and that the key question is the nature of the regulatory conditions under which they should be permitted. The discussion of autonomy in this paper helps illuminate some of these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Lewis, K., Barry, M. J., Bennett, C. L., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub5 · Cited by 6,685
Raz, J. (1988) · doi:10.1093/0198248075.001.0001 · Cited by 2,895
Decision aids for people facing health treatment or screening decisions
Stacey, D., Bennett, C. L., Barry, M. J., Col, N. F., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Légaré, F., & Thomson, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub3 · Cited by 849
Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk
Bloss, C. S., Schork, N. J., & Topol, E. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011893 · Cited by 562
Some limits of informed consent
O'Neill, O. (2003) · Journal of Medical Ethics · doi:10.1136/jme.29.1.4 · Cited by 499
Evaluating the utility of personal genomic information
Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181a2743e · Cited by 180
Neumann, P. J., Cohen, J. T., Hammitt, J. K., Concannon, T. W., Auerbach, H. R., Fang, C., & Kent, D. M. (2010) · Health Economics · doi:10.1002/hec.1704 · Cited by 139
Impact of direct-to-consumer genomic testing at long term follow-up
Bloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101207 · Cited by 137
Direct-to-Consumer Genetic Testing: Perceptions, Problems, and Policy Responses
Caulfield, T., & McGuire, A. L. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-062110-123753 · Cited by 126
Genetics, biosocial groups & the future of identity
Hacking, I. (2006) · Daedalus · doi:10.1162/daed.2006.135.4.81 · Cited by 113
Cited by
Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape
Kalokairinou, L., Howard, H. C., Slokenberga, S., Fisher, E., Flatscher-Thöni, M., Hartlev, M., van Hellemondt, R., Juškevičius, J., Kapelenska-Pregowska, J., Kováč, P., et al. (2018) · Journal of Community Genetics · doi:10.1007/s12687-017-0344-2 · Cited by 93
Third party interpretation of raw genetic data: an ethical exploration
Badalato, L., Kalokairinou, L., & Borry, P. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.126 · Cited by 61
Perego, U. A., Bodner, M., Raveane, A., Woodward, S. R., Montinaro, F., Parson, W., & Achilli, A. (2019) · Forensic Science International: Genetics · doi:10.1016/j.fsigen.2019.05.007 · Cited by 16
Metadata
- Authors
- Vayena, E.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Vayena, Effy
- ORCID
- Vayena, Effy
- Venue
- Journal of Medical Ethics
- Publisher
- BMJ
- Published
- 2014-05-05
- Volume
- 41
- Issue
- 4
- Pages
- 310-314
- ISSN
- 0306-6800 (ISSN-L)
- 1473-4257
- PMC
- PMC4392219
- OpenAlex
- W2102719677
- Cited by
- 62
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 10 · 2015: 4 · 2014: 5
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Journal of Medical Ethics (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Social Sciences › Law › Medical and Health Sciences Research
- Keywords
- direct-to-consumer genetic testing, individual autonomy, Joseph Raz, manipulation, consumer autonomy, 23andMe, genetic privacy, regulatory policy
- MeSH terms
- Commerce, Community Participation, Genetic Counseling, Genetic Testing, Humans, Public Policy, United States, United States Food and Drug Administration, Genomics, Personal Autonomy, Marketing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct-to-consumer genomics on the scales of autonomy. https://app.cochat.ai/papers/10.1136/medethics-2014-102026
- The paper
- Vayena, E. (2015). Direct-to-consumer genomics on the scales of autonomy. Journal of Medical Ethics. https://doi.org/10.1136/medethics-2014-102026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.